New UTI pill shows fast symptom relief in women and teens
NCT ID NCT06597344
First seen Feb 12, 2026 · Last updated May 15, 2026 · Updated 11 times
Summary
This study tested an oral antibiotic called gepotidacin in 97 female participants aged 12 and older with uncomplicated urinary tract infections. The goal was to see if symptoms like pain and urgency improved within 24 hours. Results showed that most participants felt better quickly without needing other antibiotics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY TRACT INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Modesto, California, 95350-5365, United States
-
GSK Investigational Site
Pasadena, California, 91101-2453, United States
-
GSK Investigational Site
San Diego, California, 92120-5259, United States
-
GSK Investigational Site
Valencia, California, 91355, United States
-
GSK Investigational Site
Miami, Florida, 33135, United States
-
GSK Investigational Site
Ormond Beach, Florida, 32174-6302, United States
-
GSK Investigational Site
Palm Springs, Florida, 33406-7671, United States
-
GSK Investigational Site
Palm Springs, Florida, 33461, United States
-
GSK Investigational Site
Plant City, Florida, 33563-4202, United States
-
GSK Investigational Site
Sweetwater, Florida, 33172-2741, United States
-
GSK Investigational Site
West Palm Beach, Florida, 33409-3401, United States
-
GSK Investigational Site
West New York, New Jersey, 07093-2622, United States
-
GSK Investigational Site
New York, New York, 10016-7313, United States
-
GSK Investigational Site
Dayton, Ohio, 45424, United States
-
GSK Investigational Site
Forney, Texas, 75126-4174, United States
-
GSK Investigational Site
Houston, Texas, 77036, United States
-
GSK Investigational Site
Houston, Texas, 77087, United States
-
GSK Investigational Site
Kingwood, Texas, 26537, United States
-
GSK Investigational Site
Mesquite, Texas, 75149, United States
-
GSK Investigational Site
Missouri City, Texas, 77459-4756, United States
-
GSK Investigational Site
Bountiful, Utah, 84010-4943, United States
-
GSK Investigational Site
Morgantown, West Virginia, 26501, United States
Conditions
Explore the condition pages connected to this study.